PP01.63 Real-World Assessment of Clinical Outcomes Associated with Immunotherapy (IO) and chemotherapy in Non–Small Cell Lung Cancer (NSCLC) Patients with Brain Metastases and METexon14 Skipping Mutations Treated in US Community Centers
Autor: | Cai, B., Arnold Egloff, S.A., Goyal, R.K., Caro, N., Frost, M., Mahmud, S., Ansquer, V.D., Davis, K.L., Brisbin, L., Lisi, M., McKenzie, A.J., Paulson, S. |
---|---|
Zdroj: | In Journal of Thoracic Oncology March 2023 18(3) Supplement:e37-e37 |
Databáze: | ScienceDirect |
Externí odkaz: |